Compound C108,98.66%

产品编号:Bellancom-131649| CAS NO:15533-09-2| 分子式:C15H14N2O3| 分子量:270.28

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-131649
1400.00 杭州 北京(现货)
Bellancom-131649
2240.00 杭州 北京(现货)
Bellancom-131649
4480.00 杭州 北京(现货)
Bellancom-131649
7140.00 杭州 北京(现货)
Bellancom-131649
11480.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Compound C108

产品介绍 Compound C108 是一种 G3BP2 抑制剂。Compound C108 也靶向应激颗粒相关蛋白、GTPase 激活蛋白 (SH3 结构域) 结合蛋白 2。Compound C108 显著抑制食管鳞状细胞癌 (ESCC) 细胞转移。
生物活性

Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis.

体外研究

Compound C108 (1 μM; 24 h) 对 BT474 细胞具有抗肿瘤活性
Compound C108 (4 μM; 24 h) 显著降低过表达 G3BP2 的 KYSE410 细胞和转染 LINC01554的 KYSE30 细胞中 G3BP2 蛋白的表达
Compound C108 (4 μM; 24 h) 减弱 KYSE410、KYSE30 和 KYSE150 细胞的 ESCC 细胞转移、迁移和侵袭

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis

Cell Line: G3BP2-overexpressing KYSE410 cells, LINC01554-transfected KYSE30 cells
Concentration: 4 μM
Incubation Time: 24 h
Result: Decreased the protein level of G3BP2 and HDGF.
体内研究
(In Vivo)

Compound C108 (1 μM; 24 h) 靶向并减少肿瘤起始细胞 (TICs),当把 Compound C108 处理过的 BT-474 细胞注射到雌性非肥胖糖尿病/严重联合免疫缺陷 (NOD-SCID) 小鼠的乳腺脂肪垫中,进行有限稀释异种移植试验时,Compound C108 导致肿瘤起始细胞 (TICs) 数目降低

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Compound C108 (1 μM; 24 h) 靶向并减少肿瘤起始细胞 (TICs),当把 Compound C108 处理过的 BT-474 细胞注射到雌性非肥胖糖尿病/严重联合免疫缺陷 (NOD-SCID) 小鼠的乳腺脂肪垫中,进行有限稀释异种移植试验时,Compound C108 导致肿瘤起始细胞 (TICs) 数目降低

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Compound C108 (1 μM; 24 h) 靶向并减少肿瘤起始细胞 (TICs),当把 Compound C108 处理过的 BT-474 细胞注射到雌性非肥胖糖尿病/严重联合免疫缺陷 (NOD-SCID) 小鼠的乳腺脂肪垫中,进行有限稀释异种移植试验时,Compound C108 导致肿瘤起始细胞 (TICs) 数目降低

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状Solid
溶解性数据
In Vitro: 

DMSO : 25 mg/mL (92.50 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.6999 mL 18.4993 mL 36.9987 mL
5 mM 0.7400 mL 3.6999 mL 7.3997 mL
10 mM 0.3700 mL 1.8499 mL 3.6999 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服